chr5-64200847-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001113561.2(RNF180):c.40C>A(p.Gln14Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,611,324 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001113561.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RNF180 | NM_001113561.2 | c.40C>A | p.Gln14Lys | missense_variant | 2/8 | ENST00000389100.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RNF180 | ENST00000389100.9 | c.40C>A | p.Gln14Lys | missense_variant | 2/8 | 1 | NM_001113561.2 | P1 | |
RNF180 | ENST00000296615.10 | c.40C>A | p.Gln14Lys | missense_variant | 2/5 | 1 | |||
RNF180 | ENST00000504296.1 | c.40C>A | p.Gln14Lys | missense_variant | 2/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152160Hom.: 0 Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1459164Hom.: 0 Cov.: 28 AF XY: 0.00000138 AC XY: 1AN XY: 726198
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74324
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 18, 2024 | The c.40C>A (p.Q14K) alteration is located in exon 2 (coding exon 1) of the RNF180 gene. This alteration results from a C to A substitution at nucleotide position 40, causing the glutamine (Q) at amino acid position 14 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at